Immune checkpoint inhibitor myocarditis and hypophysitis mimicking infective endocarditis

28 August 2026 (11:33 - 11:45)

Organised by:

Slides

Sign in for access options

About the speaker

Doctor Robin Van Lerberghe

University of Leuven, Leuven (Belgium)

4 More presentations in this session

Presentation thumbnail

Uncommon cause of multiple systemic embolism – cancer-related multivalve non infective endocarditis

Doctor C. Paraschiv (Bucharest, RO)

Presentation thumbnail

Cardio-oncology decision-making during trastuzumab-related cardiac dysfunction in high-risk HER2-positive breast cancer: a permissive cardiotoxicity approach

Doctor D. Ortega Gomez (Bogota, CO)

Presentation thumbnail

Breaking and fixing the heart - a case of trastuzumab-induced cancer therapy-related cardiac dysfunction

Doctor A. Fonseca Vazao (Leiria, PT)

Presentation thumbnail

Steroid-resistant fulminant immune checkpoint inhibitor-associated myocarditis

Doctor I. Katsoularis (Umea, SE)

Access the full session

Session thumbnail

Cardio-oncology beyond cardiotoxicity

The Event

Event poster

ESC Congress 2026

28 August 2026 11:33 CET

You may be interested in

Congress Presentation

Immune checkpoint inhibitor-associated myocarditis: clinical characteristics, management, and outcomes from a tertiary cardio-oncology unit

21 June 2025

Congress Session

Therapeutic modulation of the immune system in cardiovascular diseases

31 August 2024

Webinar

How to manage cancer therapy-related cardiovascular toxicity. ESC 2022 Clinical Practice Guidelines - Webinar Series

19 September 2022

Congress Session

Rare causes of heart failure

18 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources